Should patients with end‐stage alcoholic liver disease have a new liver?

Hepatology

Volumn 11, Issue 2, 1990, Pages 314-319

  Schenker, Steven ^a,b   Perkins, Henry S ^a,b   Sorrell, Michael F ^c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL ABUSE; EDITORIAL; HUMAN; LIVER CIRRHOSIS; LIVER DISEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL;

ALCOHOL ABUSE; CHRONICALLY ILL; CLINICAL APPROACH/SOURCE; COSTS AND BENEFITS; HEALTH CARE AND PUBLIC HEALTH; PROFESSIONAL PATIENT RELATIONSHIP; RESOURCE ALLOCATION; SCARCITY; SELF INDUCED ILLNESS; STIGMATIZATION; TRANSPLANT RECIPIENTS;

ETHICS; HEPATITIS, ALCOHOLIC; HUMAN; LIVER CIRRHOSIS, ALCOHOLIC; LIVER TRANSPLANTATION; PATIENT COMPLIANCE; THEOLOGY; TISSUE DONORS;

EID: 0025268325     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.1840110223     Document Type: Editorial

References (54)

1. Liver transplantation: medical progress
2. Orthotopic liver transplantation for alcoholic liver disease
3. Prednisone withdrawal followed by recombinant alpha‐interferon in the treatment of chronic type B hepatitis: a randomized controlled trial
4. A randomized double‐blind placebocontrolled trial of alpha‐interferon therapy for non‐A, non‐B hepatitis [Abstract]
5. Natural history of alcoholic hepatitis. II. The long term prognosis
6. Duration of survival in patients with Laennec's cirrhosis
7. Cirrhotic portal hypertension: morbidity of continued alcoholism
8. Prospective study of alcoholism treatment: eight‐year follow‐up
9. Clinical investigation of the portacaval shunt. II. Survival analysis of the prophylactic operation
10. Prophylactic portacaval anastomosis in cirrhotic patients with esophageal varices
11. Continued heavy drinking and survival in alcoholic cirrhotics
12. Effect of short‐term therapy with propylthiouracil in patients with alcoholic liver disease
13. Methylprednisolone therapy in patients with severe alcoholic hepatitis: a randomized trial
14. Longterm treatment of alcoholic liver disease with propylthiouracil
15. Double blind, controlled trial of propylthiouracil in patients with severe alcoholic hepatitis
16. Short‐term and long‐term survival in patients with alcoholic hepatitis treated with oxandrolone and prednisolone
17. Testosterone treatment of men with alcoholic cirrhosis: a double‐blind study
18. The University of Chicago Medical Housestaff. A randomized clinical trial of insulin and glucagon infusion for treatment of alcoholic hepatitis: progress report in 50 patients
19. A prospective multicenter study of insulin and glucagon infusion therapy in acute alcoholic hepatitis
20. Colchicine in the treatment of cirrhosis of the liver
21. Colchicine treatment of cirrhosis: questions
22. Treatment of alcoholic liver disease
23. Alcoholic liver disease: evaluation of natural history and prognostic factors
24. The effects of alcoholism on skeletal and cardiac muscle
25. Orthotopic liver transplantation for alcoholic cirrhosis
26. Reliability of assessment of alcohol intake based on personal interviews in a liver clinic
27. Results of orthotopic liver transplantation (OLT) in alcoholic cirrhosis
28. Orthotopic liver transplantation: primary therapy for alcoholic cirrhosis [Abstract]
29. Selection of patients with alcoholic liver disease for orthotopic liver transplantation [Abstract]
30. Medical treatment vs. transplantation in liver disorders
31. Nutritional management and assessment
32. Malnutrition and immunocompetence in patients with liver disease
33. The perioperative patient
34. VA cooperative study on alcoholic hepatitis. II. Prognostic significance of protein‐calorie malnutrition
35. Survival from hepatic transplantation: relationship of protein synthesis to histological abnormalities in patient selection and postoperative management
36. Amino acid clearance in cirrhosis: a prediction of postoperative morbidity and mortality
37. Liver transplantation of chronic viral hepatitis B
38. Preoperative evaluation, preparation and timing of orthotopic liver transplantation in the adult
39. Genetic influences in alcoholism
40. The alcoholic in the lifeboat. Should drinkers be candidates for liver transplantation?
41. Successful 24‐ to 30‐hour preservation of the canine liver: a preliminary report
42. Extended preservation of human liver grafts with VW solution
43. Liver transplantation with reduced‐size donor organs
44. Ethics of liver transplantation with liver donors
45. Organ donor recruitment
46. Liver procurement for orthotopic transplantation: an analysis of the Pittsburgh experience
47. The organ procurement problem: many causes, no easy solutions
48. Health care tickets for the uninsured: first class, coach, or standby?
49. Starting a liver transplant program